Options Brief: Amylin Pharmaceuticals

Shares of Amylin Pharmaceuticals AMLN are lower on the session by 0.15%, trading at $12.91. Overall call volume is now running at 4.41x the daily average, with 61% of all calls traded being purchases on the offer. 3,634 contracts have traded on the session so far. Amylin Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the discovery, development and commercialization of drug candidates for the treatment of diabetes, obesity and other diseases.